Tag: drug discovery

Jan 13, 20267 min readFounder NotesIntermediate5 min build

Converge Bio raises $25M Series A to scale sequence-trained generative AI for antibody design and protein optimization

Converge Bio raised a $25M Series A led by Bessemer to scale sequence-trained generative AI across discovery-to-manufacturing. It already ships antibody-design and protein-yield tools.

Converge Bio AI drug discovery generative models Series A

+3 more